Nature

PI-RADS score v.2 in predicting malignancy in patients undergoing 5α-reductase inhibitor therapy

To investigate if the PI-RADS score represents an effective tool in detecting prostate cancer in patients treated with a 5α-reductase inhibitor (dutasteride) and to identify dedicated total serum PSA ...
ascopubs.org

The positive predictive value of PI-RADS 4 lesions stratified by lesion number in biopsy naïve men.

Temporal trends and factors associated with overuse of neoadjuvant androgen deprivation therapy in low and very low risk prostate cancer. Changes in multiparametric prostate MRI and immune subsets in ...
Medical Xpress

Prostate cancer upgrade, downgrade rates in PI-RADS 2.0 versus 2.1

According to a study published in the American Journal of Roentgenology (AJR), upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between ...
Nature

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate

To evaluate if follow-up mpMRI scans of patients in PI-RADS category 3 are safe enough to omit or delay prostate biopsy in the future and to determine an optimal control interval. This retrospective ...
ascopubs.org

The accuracy of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS v2 in disease upgrading on re-biopsy among patients with low-risk prostate cancer (PCa) on ...

Survival impact of initial local therapy selection for men under 60 with high risk prostate cancer. Prostate cancer (PCa) in 696 hypogonadal men with and without long-term testosterone therapy (TTh): ...
EurekAlert!

Prostate cancer upgrade, downgrade rates in PI-RADS 2.0 versus 2.1

Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...